HUTCHMED
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
Boehringer Ingelheim has been committed to providing innovative treatments in Human and Animal Health for over 130 years. Boehringer Ingelheim is a family-owned, R&D-driven company and one of the top 20 pharmaceutical companies in the world. Our employees create value through innovation in Human Health, Animal Health and contract manufacturing of biopharmaceuticals.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
At Boehringer Ingelheim, the development of medicines for people and animals is at the heart of our work. Our mission is to develop innovative therapies that change lives. Since its founding in 1885, Boehringer Ingelheim has been an independent family company. We are free to pursue our long-term vision, anticipating the health challenges of the future and targeting those areas of need where we can deliver the greatest benefits
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
As a leading research-driven biopharmaceutical company Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. The Regional Center Vienna is responsible for the business in Austria and more than thirty countries in Central and Eastern Europe and Central Asia, as well as Switzerland and Israel and is also the group’s main cancer research site.
Roche is one of the biggest healthcare companies in the world; headquartered in Switzerland.
We are a fast-growing, international biotech company committed to our goal of improving the lives of patients through innovative and differentiated
antibody therapeutics.
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
On 20th February 1968, Bayer East Africa Limited representing Bayer AG was formed. enya is a country in East Africa near the horn of Africa. Kenya is home to many different indigenous peoples with their own cultures, languages, and histories. Kenya hosts Bayer East Africa Ltd which is the regional office serving Kenya, Ethiopia, Tanzania, Uganda, Burundi and Rwanda. Operating Divisions, include:
Crop Science
Pharmaceuticals, and
Consumer Health.